Last mentioned: Mar 8, 2026
Industry Consensus
Scientific American and other major outlets report a definitive decline in global animal experiment volumes.
Major CRO Pivot
Leading Contract Research Organizations announce multi-million dollar investments in digital twin and OOC labs.
FDA Guidance on NAMs
The FDA issues initial framework for the submission of data derived from microphysiological systems.
FDA Modernization Act 2.0
President Biden signs legislation ending the mandate for animal testing for new drug applications.
The long-standing paradigm of animal experimentation is facing an unprecedented decline as regulatory frameworks and advanced biotechnologies converge. Following the landmark FDA Modernization Act 2.0, the industry is pivoting toward 'New Approach Methodologies' that promise higher human predictive value and lower development costs.
This page surfaces every story mentioning Emulate, Inc. across our healthcare coverage. We track each entity's appearance over time so readers can trace how the narrative evolves — which developments are isolated incidents, which build into longer arcs, and which reframe how operators in the space think about the entity. Story selection uses the same multi-source verification gate applied across the rest of our coverage.
Read our editorial methodology for how we identify, deduplicate, and score entity references. Our glossary defines the technical terms used across stories on this page, and our trends index contextualizes individual developments against the longer-running healthcare beat. Cross-entity comparisons live on our compare view.
| What you see | What it tells you |
|---|---|
| Story count | Number of distinct stories where Emulate, Inc. was a primary or referenced actor. |
| Recency clustering | Whether mentions are concentrated in a recent window (a news cycle) or distributed (a sustained arc). |
| Sentiment distribution | Aggregate sentiment of the stories mentioning this entity, weighted by impact score. |
| Cross-niche links | When the same entity surfaces in our sibling networks, we link to those views to enrich context. |